SCHEMBL30459796

SCHEMBL30459796

O=C1N=Cc2cc(CBr)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20300390 0.81 CHEK1 (0.38)
SCHEMBL31098567 0.81 GAA (0.41)
SCHEMBL30503673 0.81 CHEK1 (0.38)
SCHEMBL29289892 0.81 GAA (0.41)
SCHEMBL481795 0.75 S100A4 (0.45)
SCHEMBL30851303 0.74 CACNA1G (0.31)
SCHEMBL18939906 0.71
SCHEMBL1162921 0.71 NPC1 (0.41)
SCHEMBL31098477 0.71 ESR2 (0.45)
SCHEMBL15284506 0.71 CA1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 WO disclosed